Shen S - Search Results

1

Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.

Anzueto AR, Kostikas K, Mezzi K, Shen S, Larbig M, Patalano F, Fogel R, Banerji D, Wedzicha JA. Anzueto AR, et al. Among authors: shen s. Respir Res. 2018 Jun 20;19(1):121. doi: 10.1186/s12931-018-0830-z. Respir Res. 2018. PMID: 29925383 Free PMC article. Clinical Trial.

2

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD.

Anzueto AR, Vogelmeier CF, Kostikas K, Mezzi K, Fucile S, Bader G, Shen S, Banerji D, Fogel R. Anzueto AR, et al. Among authors: shen s. Int J Chron Obstruct Pulmon Dis. 2017 May 4;12:1325-1337. doi: 10.2147/COPD.S133307. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28496316 Free PMC article.

3

Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program.

Tsiligianni I, Mezzi K, Fucile S, Kostikas K, Shen S, Banerji D, Fogel R. Tsiligianni I, et al. Among authors: shen s. COPD. 2017 Aug;14(4):375-381. doi: 10.1080/15412555.2017.1324837. Epub 2017 Jun 8. COPD. 2017. PMID: 28594587 Free article. Clinical Trial.

4

Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study.

Papi A, Kostikas K, Wedzicha JA, Vogelmeier CF, Roche N, Shen S, Banerji D, Fogel R, Patalano F, Chapman KR. Papi A, et al. Among authors: shen s. Am J Respir Crit Care Med. 2018 May 1;197(9):1223-1226. doi: 10.1164/rccm.201709-1822LE. Am J Respir Crit Care Med. 2018. PMID: 29099609 No abstract available.

5

Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME.

Frent SM, Chapman KR, Larbig M, Mackay A, Fogel R, Gutzwiller FS, Shen S, Patalano F, Banerji D, Kostikas K, Wedzicha JA. Frent SM, et al. Among authors: shen s. Am J Respir Crit Care Med. 2019 Jan 1;199(1):43-51. doi: 10.1164/rccm.201801-0038OC. Am J Respir Crit Care Med. 2019. PMID: 30019939 Free PMC article. Clinical Trial.

6

Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study.

Wedzicha JA, Singh D, Tsiligianni I, Jenkins C, Fucile S, Fogel R, Shen S, Goyal P, Mezzi K, Kostikas K. Wedzicha JA, et al. Among authors: shen s. Respir Res. 2019 Jan 8;20(1):4. doi: 10.1186/s12931-019-0972-7. Respir Res. 2019. PMID: 30621717 Free PMC article. Clinical Trial.

7

COPD clinical control as a predictor of future exacerbations: concept validation in the SPARK study population.

Barrecheguren M, Kostikas K, Mezzi K, Shen S, Alcazar B, Soler-Cataluña JJ, Miravitlles M, Wedzicha JA. Barrecheguren M, et al. Among authors: shen s. Thorax. 2020 Apr;75(4):351-353. doi: 10.1136/thoraxjnl-2018-212752. Epub 2020 Feb 10. Thorax. 2020. PMID: 32041741

8

Comparison of glycopyrronium versus tiotropium on the time to clinically important deteriorations in patients with COPD: a post-hoc analysis of randomized trials.

D'Urzo A, Bader G, Shen S, Goyal P, Altman P. D'Urzo A, et al. Among authors: shen s. NPJ Prim Care Respir Med. 2018 May 24;28(1):18. doi: 10.1038/s41533-018-0084-8. NPJ Prim Care Respir Med. 2018. PMID: 29795478 Free PMC article.

9

KalmanFormer: using transformer to model the Kalman Gain in Kalman Filters.

Shen S, Chen J, Yu G, Zhai Z, Han P. Shen S, et al. Front Neurorobot. 2025 Jan 7;18:1460255. doi: 10.3389/fnbot.2024.1460255. eCollection 2024. Front Neurorobot. 2025. PMID: 39840232 Free PMC article.

10

Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease.

Liu G, Hsu AC, Geirnaert S, Cong C, Nair PM, Shen SS, Marshall J, Haw TJ, Fricker M, Philp AM, Hansbro NG, Pavlidis S, Guo Y, Burgess JK, Castellano L, Ieni A, Caramori G, Oliver BG, Chung KF, Adcock IM, Knight DA, Polverino F, Bracke K, Wark PA, Hansbro PM. Liu G, et al. Among authors: shen ss. Mol Ther. 2025 Jan 21:S1525-0016(25)00036-X. doi: 10.1016/j.ymthe.2025.01.032. Online ahead of print. Mol Ther. 2025. PMID: 39838644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,749 results

Search Page

Filters